Samina Kajani, FNP

Samina Kajani practices at Mercy Medical Group, a Service of Dignity Health Medical Foundation in Carmichael, California.

Samina Kajani's NPI, 1548815707, was assigned on August 5, 2019. Samina Kajani holds California license 95011728.

Samina Kajani's primary practice is Mercy Medical Group, a Service of Dignity Health Medical Foundation, at 6555 Coyle Ave, Carmichael, CA 95608 in Sacramento County. The practice phone is (916) 733-3397.

Samina Kajani's primary practice is Mercy Medical Group, a Service of Dignity Health Medical Foundation in Carmichael, California. Samina Kajani is also affiliated with Dignity Health - Mercy San Juan Medical Center. The medical group on file is Mercy Medical Group. Dmand AI also links Samina Kajani to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Samina Kajani practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Samina Kajani's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Samina Kajani is licensed in California.

Dmand AI lists anxiety, asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pneumonia and pulmonary fibrosis among the conditions Samina Kajani treats.

CMS data shows 731 Medicare services from Samina Kajani across 6 procedure codes in 2024, for 352 Medicare patients. Medicare paid $62,682 for them. Every service was in an office.

CMS counts 352 Medicare patients who saw Samina Kajani in 2024. The largest group is 65 to 74, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Samina Kajani's median patient age at 70, with 58% women.

In 2024, Samina Kajani wrote 2,626 Medicare Part D claims for 385 patients. 39% of them were for generic drugs. CMS names the drug for 2,531 of them, across 32 drugs with 11 or more claims each, at $830,745 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Samina Kajani for performance year 2024, reported through an alternative payment model (APM). Samina Kajani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Samina Kajani as offering telehealth.

CMS Open Payments shows 12 general payments to Samina Kajani from 10 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $60.